Taysha Gene Therapies, Inc. financial data

Symbol
TSHA on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
3000 Pegasus Park Drive, Suite 1430, Dallas, TX
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Feb 26, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 477 % +243%
Debt-to-equity 115 %
Return On Equity -111 % -107%
Return On Assets -51.5 % +36.4%
Operating Margin -1.1K % -134%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 205M shares +9.62%
Common Stock, Shares, Outstanding 205M shares +9.62%
Entity Public Float 371M USD +1119%
Common Stock, Value, Issued 2K USD 0%
Weighted Average Number of Shares Outstanding, Basic 250M shares +115%
Weighted Average Number of Shares Outstanding, Diluted 250M shares +115%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 8.33M USD -46.1%
Research and Development Expense 66M USD +16.2%
General and Administrative Expense 29M USD -3.64%
Operating Income (Loss) -91.5M USD -26.3%
Nonoperating Income (Expense) 2.16M USD -98.2%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -89.3M USD +20%
Earnings Per Share, Basic -0.36 USD/shares +62.5%
Earnings Per Share, Diluted -0.36 USD/shares +62.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 139M USD -3.41%
Other Assets, Current 308K USD +5.48%
Assets, Current 142M USD -5.16%
Property, Plant and Equipment, Net 7.49M USD -30.9%
Operating Lease, Right-of-Use Asset 8.38M USD -12.5%
Other Assets, Noncurrent 217K USD -28.6%
Assets 160M USD -7.16%
Accounts Payable, Current 3.59M USD -43.6%
Employee-related Liabilities, Current 5.24M USD +53.1%
Liabilities, Current 26.2M USD -28.6%
Operating Lease, Liability, Noncurrent 17.4M USD -8.4%
Other Liabilities, Noncurrent 1.31M USD -17%
Liabilities 88.8M USD -9.16%
Accumulated Other Comprehensive Income (Loss), Net of Tax -4.03M USD
Retained Earnings (Accumulated Deficit) -602M USD -17.4%
Stockholders' Equity Attributable to Parent 71.5M USD -4.55%
Liabilities and Equity 160M USD -7.16%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -19.8M USD +1.92%
Net Cash Provided by (Used in) Financing Activities -370K USD -246%
Net Cash Provided by (Used in) Investing Activities -140K USD +96.4%
Common Stock, Shares Authorized 400M shares 0%
Common Stock, Shares, Issued 205M shares +9.62%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -20M USD +18.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.33M USD +18.1%
Deferred Tax Assets, Valuation Allowance 114M USD +24%
Deferred Tax Assets, Gross 116M USD +23.1%
Operating Lease, Liability 18.8M USD -6.91%
Depreciation 1.25M USD -9.19%
Payments to Acquire Property, Plant, and Equipment 140K USD -96.4%
Lessee, Operating Lease, Liability, to be Paid 27.7M USD -9.15%
Property, Plant and Equipment, Gross 11.1M USD -19.8%
Operating Lease, Liability, Current 1.49M USD +15%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.49M USD -14.6%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.91M USD +3.56%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 8.86M USD -13.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.58M USD +3.7%
Deferred Tax Assets, Operating Loss Carryforwards 57M USD +20.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.67M USD +3.73%
Operating Lease, Payments 2.74M USD +296%
Additional Paid in Capital 678M USD +15.3%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 13.1M USD +65.8%
Interest Expense 2.24M USD -56.9%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%